期刊文献+

阿立哌唑不良反应的观察与护理对策 被引量:1

下载PDF
导出
摘要 目的:观察阿立哌唑的常见不良反应及随用药时间的变化,探讨预防和减轻病人药物不良反应的护理对策。方法:对单一使用阿立哌唑治疗的精神分裂症病人应用TESS量表进行不良反应的观察与分析,并进行有针对性的护理。结果:阿立哌唑的不良反应在用药后第1周发生率最高,第2周、3、4周依次减低。常见的不良反应有头晕、震颤、心动过速、静坐不能、失眠、恶心、视物模糊、嗜睡、食欲减退、头痛、便秘、乏力、兴奋激越、尿频感。结论:阿立哌唑的不良反应的发生与服药时间有关,要根据阿立哌唑药物不良反应发生的特点有针对性的进行预防与护理。
出处 《医学信息(中旬刊)》 2010年第11期3326-3327,共2页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献4

二级参考文献35

  • 1.FDA网上公告[EB/OL].Http://www.fda.gov,.
  • 2[1]Kikuchi T, Tottori K, Uwahodo Y, et al. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl] butyloxy)-3,4-dihydro-2 ( 1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther, 1995 Jul, 274( 1 ) :329 ~ 336
  • 3[2]Fleishhacker WW. New developments in the pharmacotherapy of schizophrenia. J Neural transm Suppl, 2003, 105 ~ 117
  • 4[3]Oshiro Y, Sato S, Kurahashi N, et al. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[ 4-( 4-phenyl-1-piperazinyl ) butoxy ]-3, 4-dthydro-2 (1H)-quinolinone derivatives. J Med Chem, 1998 Feb, 41 : 658 ~667
  • 5[4]Matsubayashi H, Amano T, Sasa M. Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra. Psychopharmacolgy (Berl), 1999 Sep, 146(2) : 139 ~ 143
  • 6[5]Lawler CP, Prioleau C, Lewis MM, et al. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropschopharmacolgy, 1999 Jun, 20(6) : 612~627
  • 7[6]Inoue A, Seto M, Sugita S, et al. differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat ptiuitary. Brain Res Mol Brain Res, 1998 apr, 55 : 285 ~292
  • 8[7]Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.Neuropsychopharmacology, 2003 May
  • 9[8]Jordan S, Koprivica V, Chen R, et al. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT ( 1 A) receptor. Eur J Pharmacol, 2002 Apr 26,441(3) : 137 ~140
  • 10[9]Goodnick P J, Jerry JM. aripiprazole: profile on efficacy and safety.Expert Opin Pharmacother, 2002 Dec, 3(12) : 1773 ~ 1781

共引文献307

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部